Bayer AG (XSWX:BAYN) Inventories, Other: CHF10,935 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BAYN Bayer AG XSWX:BAYN
35 GF Score
Price CHF47.36
GF Value CHF24.67
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bayer AG Inventories, Other?

Bayer AG XSWX:BAYN +3.59% 35 Inventories, Other is CHF10,935 Mil as of Mar. 2026. GuruFocus rates XSWX:BAYN with a GF Score™ of 35/100 and a GF Value™ of CHF24.67 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Bayer AG's other inventories for the quarter that ended in Mar. 2026 was CHF10,935 Mil.

Bayer AG's quarterly other inventories declined from Sep. 2025 (CHF11,523 Mil) to Dec. 2025 (CHF79 Mil) but then increased from Dec. 2025 (CHF79 Mil) to Mar. 2026 (CHF10,935 Mil).

Bayer AG's annual other inventories declined from Dec. 2023 (CHF115 Mil) to Dec. 2024 (CHF82 Mil) and declined from Dec. 2024 (CHF82 Mil) to Dec. 2025 (CHF79 Mil).

Bayer AG Inventories, Other Historical Data

* Premium members only.

The historical data trend for Bayer AG's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Inventories, Other Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98.87 177.64 115.05 82.16 79.32

Bayer AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,119.17 11,359.48 11,522.89 79.32 10,934.82
XSWX:BAYN
35GF Score
Bayer AG XSWX:BAYN
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of CHF10,935 Mil mean?
Bayer AG (XSWX:BAYN) has a Inventories, Other of CHF10,935 Mil as of Mar. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Bayer AG and its competitors.
Is Bayer AG's Inventories, Other too high?
Bayer AG's current Inventories, Other is CHF10,935 Mil. Overall, Bayer AG has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Inventories, Other compare to LLY and JNJ?
Bayer AG's Inventories, Other of CHF10,935 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Drug Manufacturers company?
A good Inventories, Other depends on the Drug Manufacturers industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Bayer AG and its competitors. Bayer AG's current Inventories, Other is CHF10,935 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (XSWX:BAYN) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF24.67, compared to a current price of CHF47.36 — trading 92% above its estimated fair value. The current Inventories, Other is CHF10,935 Mil. Bayer AG's overall GF Score™ is 35/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For Bayer AG (XSWX:BAYN), the current Inventories, Other is CHF10,935 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (XSWX:BAYN) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of CHF47.36 is trading 92% above its estimated GF Value™ of CHF24.67. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for XSWX:BAYN:

  • Inventories, Other: CHF10,935 Mil
  • GF Value™: CHF24.67 vs. price of CHF47.36 (92% above fair value)
  • GF Score™: 35/100 with 7 warning signs

No single metric tells the full story. See the XSWX:BAYN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
35GF Score

Get the complete analysis for XSWX:BAYN

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF47.36
Price
CHF24.67
GF Value